Overview
Changlin Wang practices practicing medicine in Harbin, China.
Their clinical expertise encompasses Renal Cell Carcinoma (RCC) and Macular Corneal Dystrophy Type 1.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Changlin Wang
Is Changlin Wang a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Changlin Wang is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Changlin Wang participate in research or clinical trials?
Yes. Changlin Wang has published 10 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Changlin Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Macular Corneal Dystrophy Type 1
- Renal Cell Carcinoma (RCC)Wang isExperienced. Learn about Renal Cell Carcinoma (RCC).